Ultragenyx
Price & Volume
Stats
See more52W Range | $18.29-$39.88 |
Market Cap | $2.6B |
Shares Short | 15M |
Financials
See moreRevenue (12 Mos) | $717M |
Revenue Growth (YoY) | 28.1% |
Gross Profit (12 Mos) | -$149M |
Diluted EPS | -$5.83 |
News
See moreYahoo Finance • 3 days ago
Ultragenyx (RARE) Jumped 7.5% on FDA Approval. Can a $2.7 Million Gene Therapy Become a Commercial Success?
Yahoo Finance • 8 days ago
Premarket movers: Deere jumps following upbeat Q3, Wolfspeed plunges
Yahoo Finance • 8 days ago
Biggest stock movers Thursday: Crypto stocks, WOLF, and more
Yahoo Finance • last month
Ultragenyx to Host Conference Call for Second Quarter 2026 Financial Results and Corporate Update
About
CEO | Dr. Emil D. Kakkis M.D., Ph.D. |
CFO | Mr. Howard Horn |
Address | 60 Leveroni Court, Novato, CA, United States, 94949 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 1,371 |